Business Context and Reporting Period
This Form 8-K is filed by India Globalization Capital, Inc. (not IGC Pharma, Inc.) for the reporting period of September 26, 2011. The filing addresses the reconvened 2011 Annual Meeting of Shareholders, originally held on August 25, 2011, to vote on Proposal 3 regarding the issuance of additional shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and shareholder voting results.
Material Changes and Voting Results
The primary event reported is the failure to secure sufficient shareholder approval for the issuance of up to 5,000,000 shares of common stock to the Steven M. Oliveira 1998 Charitable Remainder Unitrust. This issuance was tied to a Note and Share Purchase Agreement dated March 24, 2011.
- Votes For (Reconvened Meeting): 6,649,704
- Votes Against: 615,961
- Percentage in Favor: Approximately 31.73% of outstanding shares cast.
- Outcome: The proposal failed to achieve the necessary majority.
Outlook, Management Commentary, and Next Steps
Due to insufficient votes to approve the stock issuance, the shareholders present unanimously approved a motion to adjourn and reconvene the meeting. The new meeting is scheduled for October 12, 2011, at 10:00 AM. The stated purpose of the adjournment is to allow additional time to solicit proxies from shareholders who had not previously voted on Proposal 3.
Investor Verification Checklist
- Verify the outcome of the reconvened shareholder meeting scheduled for October 12, 2011.
- Confirm the status of the Note and Share Purchase Agreement with the Steven M. Oliveira 1998 Charitable Remainder Unitrust given the failed vote.
- Review the company's capital structure to understand the potential dilution impact of the proposed 5,000,000 shares.
- Monitor for any subsequent filings regarding the solicitation of additional proxies.